Driving excellence in aseptic fill-finish: Our strategic partnership with Stäubli Robotics
At 3P innovation, we engineer automation with purpose - solutions that don’t just meet the demands of aseptic manufacturing but redefine what’s...
Dr. Dave Seaward : 20 January 2022
PDF File: Cell and Gene Therapy: Converting a Rolls-Royce into a Ford?
With promising applications in the personalised medicines field, Cell and Gene Therapies are becoming more and more relevant. This, alongside 3Ps experience in the manufacturing of said therapies, has inspired 3P Founder and Projects Director Dave Seaward, to write a new blog series all about ATMPs!
Click the pdf link above and take a read of the first blog in the series.
This first blog focuses around the manufacture of cell and gene therapies with an interesting analogy to the automotive industry. It also looks at how 3P innovation can help with the manufacture of these life-changing ATMPs.
At 3P innovation, we engineer automation with purpose - solutions that don’t just meet the demands of aseptic manufacturing but redefine what’s...
Pharmaceutical extrusion is a critical enabler in the manufacture of advanced drug delivery systems, from long-acting injectables to solid implants....
Before delving into some technical details of cell and gene therapy manufacturing, it’s worth pausing to reflect on the human stories that drive this...